Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Dual-action agent for BPH developed at Zeria

April 3, 1998

N-Alkylated saccharins from Merck & Co. with potential in BPH therapy

April 2, 1998

FDA approves DDAVP tablets for nocturnal enuresis in children

April 1, 1998

New vasopressin antagonist from JT with aquaretic effects in animals

April 1, 1998

Detrol approved by FDA for overactive bladder

March 30, 1998

Synaptic licenses technology for BPH treatment to Glaxo Wellcome

March 25, 1998

Genetic basis for congenital kidney disease pinpointed by BioStratum scientists

March 23, 1998

Taiwan researchers identify lead potassium channel opener selective for bladder

March 18, 1998

Use of aspirin to prevent preeclampsia should be discontinued, NIH researchers say

March 13, 1998

Detrusitol launched in U.K. and Germany

March 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...